Retrovirology

official impact factor 5.24

This article is part of the supplement: 2005 International Meeting of The Institute of Human Virology

Open Access Poster presentation

The MHC Class II Transactivator (CIITA): A "Physiologic" Drug Against HIV-1 Replication

Giovanna Tosi, Andrea DL Barbaro, Lorenzo Mortara and Roberto S Accolla*

Retrovirology 2005, 2(Suppl 1):P2 doi:10.1186/1742-4690-2-S1-P2

No comments have yet been made on this article.

Post a comment